Supplementary protection
LT - N-acil-(3-pakeisto)-(8-pakeisto)-5,6-dihidro- [1,2,4]triazol[4,3-A]pirazinai, kaip selektyvūs NK-3 receptorių antagonistai, farmacinė kompozicija, būdai, skirti naudoti NK-3 receptoriaus sąlygotų sutrikimų gydymui
EN - N-ACYL-(3-SUBSTITUTED)-(8-SUBSTITUTED)-5,6-DIHYDRO- [1,2,4]TRIAZOLO[4,3-A]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR-MEDIATED DISORDERS
SPC
| (11) |
Number of the document |
C 2948455 |
| (68) |
Number of the document |
2948455
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2024 513 |
| (22) |
Date of filing the application |
2024-05-10 |
| (41) |
Date of publication of the application |
2024-06-10 |
|
Date of publication of SPC |
|
| (24) |
Date of coming into effect of SPC |
2034-03-29 |
Applicant
| (71) |
Ogeda NV,
Medialaan 50, Vilvoorde 1800,
BE
|
Grantee
| (73) |
Ogeda NV,
Medialaan 50, Vilvoorde 1800,
BE
|
Attorney or representative
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
C(2023)8783, 2023-12-07
|
Calculated date of expiry of the SPC
| (94) |
2038-12-12 |
Name of the product protected by the basic patent
| (95) |
Fezolinetantas |
Legal status
|
SPC application published
|
|
